Clinical Research Workshop: Advancing Research Frameworks in MetALD Breakout Session, Part 2A—Designing Cohort Studies in MetALD

Nov 10 2025
Convention Center: Room 207, Level 2
3:45 PM - 4:45 PM

World Class Speakers

Marina Serper, MD, MS
Presenter

Marina Serper, MD, MS

University of Pennsylvania Health System
GC
Presenter

George Cholankeril, MD, MSECR

Baylor College of Medicine
Christine Hsu, MD
Moderator

Christine Hsu, MD

National Institute of Diabetes, Digestive

Description

Experts provide an overview of the latest innovations in study design in MetALD-induced liver disease, including study endpoints. Presenters explore how to design and conduct effective cohort studies, large database studies, and clinical trials. Topics include the role of investigator-initiated cohort studies, large national database studies, and clinical trials in MetALD with discussion of funding opportunities, monitoring, and conducting these studies with a focus on early-stage investigators. This interactive session provides an opportunity to discuss study methodologies, existing studies, and protocols with the moderators.

 

 

Journey Maps

Presentations

3:45 PM - 4:05 PM
Nov 10 2025
Washington, D.C.

Breakout 2A: Designing Cohort Studies in MetALD

Marina Serper, MD, MS, Presenter
ALD
MASLD
4:05 PM - 4:25 PM
Nov 10 2025
Washington, D.C.

Breakout 2A: Designing Cohort Studies in MetALD

George Cholankeril, MD, MSECR, Presenter
ALD
MASLD
4:25 PM - 4:45 PM
Nov 10 2025
Washington, D.C.

Q&A

Christine Hsu, MD, Moderator
ALD
MASLD

Objectives

  • Identify critical considerations and translational strategies for developing a MetALD research program.
  • Discuss study designs, end points, and innovations in MetALD clinical trials.
  • Review best practices for investigator-initiated cohort studies, large database studies, and clinical trials in MetALD.